Wall Street woke up Monday to a familiar summer ritual: the Fed is expected to do very little, Nvidia is doing entirely too much, and investors are pretending this is all perfectly normal. The result is a market narrative with just enough…
Amwell’s (AMWL) leadership page reads like a small thesis on where digital care is trying to go: a mix of clinicians, operators, and technologists built to make virtual healthcare feel less like a workaround and more like a workflow. That matters because…
Nvidia says the AI trade is still alive and kicking, while the market’s skeptics keep sharpening their pencils. The result is a familiar Wall Street tableau: one camp sees an infrastructure supercycle, the other sees a very expensive game of musical chairs.…
Elon Musk’s latest The Insider turn is vintage Musk: audacious, unsettling, and just coherent enough to make everyone in the room check their assumptions. In his conversation with Zanny Minton Beddoes, he argued that AI and robots could make work optional, money…
Eli Lilly-backed Scribe Therapeutics is having the kind of debut that makes Wall Street reach for a second coffee: the CRISPR company priced an upsized IPO, then saw its shares jump sharply in trading, a rare show of enthusiasm for an early-stage…
U.S. equities closed mixed to lower for the week after a risk-off stretch tied to higher energy prices, rising Treasury yields earlier in the week, and fresh scrutiny on earnings quality and AI spending discipline. By Friday’s close, the S&P 500 finished…
U.S. equities finished lower on Thursday as investors digested a hotter risk backdrop, softer sentiment in mega-cap technology, and a fresh jump in oil and Treasury yields. The move added to concerns that higher energy prices could keep inflation sticky just as…
Jamie Dimon’s latest interview had the kind of calm, polished menace Wall Street loves: the economy is sturdy, AI is real, bonds are not his favorite date, and government deficits are the sort of thing that tend to arrive uninvited and stay…
Wall Street is getting three reminders at once: geopolitics can still move oil and yields, defense demand remains durable, and medtech innovation is still finding ways to surprise investors. The result is a market story that feels less like a single headline…
U.S. stocks finished Wednesday with a mixed but relatively calm tone: the S&P 500 (^GSPC) rose 0.1% to 7,498.96, the Dow Jones Industrial Average (^DJI) slipped less than 0.1% to 52,218.58, and the Nasdaq Composite (^IXIC) fell 0.6% to 25,690.90. The move…